LGND logo

LGND Current assets

annual current assets:

$331.56M+$94.13M(+39.65%)
December 31, 2024

Summary

  • As of today (June 4, 2025), LGND annual total current assets is $331.56 million, with the most recent change of +$94.13 million (+39.65%) on December 31, 2024.
  • During the last 3 years, LGND annual current assets has fallen by -$133.19 million (-28.66%).
  • LGND annual current assets is now -70.49% below its all-time high of $1.12 billion, reached on December 31, 2019.

Performance

LGND Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

quarterly current assets:

$309.32M-$22.24M(-6.71%)
March 31, 2025

Summary

  • As of today (June 4, 2025), LGND quarterly total current assets is $309.32 million, with the most recent change of -$22.24 million (-6.71%) on March 31, 2025.
  • Over the past year, LGND quarterly current assets has dropped by -$59.60 million (-16.15%).
  • LGND quarterly current assets is now -82.28% below its all-time high of $1.75 billion, reached on September 30, 2018.

Performance

LGND quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

LGND Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+39.6%-16.1%
3 y3 years-28.7%+12.0%
5 y5 years-70.5%-62.8%

LGND Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-28.7%+39.6%-16.1%+40.3%
5 y5-year-70.5%+39.6%-64.2%+40.3%
alltimeall time-70.5%+1291.8%-82.3%+2023.0%

LGND Current assets History

DateAnnualQuarterly
Mar 2025
-
$309.32M(-6.7%)
Dec 2024
$610.22M(+11.0%)
$331.56M(+7.2%)
Sep 2024
-
$309.39M(-0.9%)
Jun 2024
-
$312.26M(-15.4%)
Mar 2024
-
$368.91M(+55.4%)
Dec 2023
$549.79M(+10.2%)
$237.43M(-6.5%)
Sep 2023
-
$253.99M(-8.2%)
Jun 2023
-
$276.71M(-15.7%)
Mar 2023
-
$328.19M(+24.5%)
Dec 2022
$499.07M(-40.1%)
$263.60M(+19.6%)
Sep 2022
-
$220.43M(-9.6%)
Jun 2022
-
$243.78M(-11.7%)
Mar 2022
-
$276.07M(-40.6%)
Dec 2021
$832.84M(-3.4%)
$464.75M(+7.6%)
Sep 2021
-
$432.08M(+5.2%)
Jun 2021
-
$410.90M(-6.1%)
Mar 2021
-
$437.43M(-12.6%)
Dec 2020
$861.73M(+132.1%)
$500.56M(-41.6%)
Sep 2020
-
$857.74M(-0.7%)
Jun 2020
-
$863.62M(+4.0%)
Mar 2020
-
$830.73M(-26.1%)
Dec 2019
$371.27M(-4.9%)
$1.12B(-5.0%)
Sep 2019
-
$1.18B(-18.0%)
Jun 2019
-
$1.44B(-8.0%)
Mar 2019
-
$1.57B(+80.1%)
Dec 2018
$390.26M(-10.1%)
$870.54M(-50.1%)
Sep 2018
-
$1.75B(+17.9%)
Jun 2018
-
$1.48B(+324.1%)
Mar 2018
-
$349.05M(+47.3%)
Dec 2017
$434.00M(-1.0%)
$237.02M(+5.7%)
Sep 2017
-
$224.20M(+13.7%)
Jun 2017
-
$197.18M(+12.9%)
Mar 2017
-
$174.70M(+7.1%)
Dec 2016
$438.53M(+52.1%)
$163.05M(+15.9%)
Sep 2016
-
$140.69M(+11.2%)
Jun 2016
-
$126.56M(-4.9%)
Mar 2016
-
$133.06M(-38.0%)
Dec 2015
$288.35M(+295.7%)
$214.71M(+2.1%)
Sep 2015
-
$210.32M(+6.9%)
Jun 2015
-
$196.72M(+2.6%)
Mar 2015
-
$191.71M(+3.5%)
Dec 2014
$72.87M(-8.7%)
$185.16M(-6.7%)
Sep 2014
-
$198.52M(+594.5%)
Jun 2014
-
$28.59M(-14.4%)
Mar 2014
-
$33.40M(+34.3%)
Dec 2013
$79.83M(-0.8%)
$24.88M(+49.6%)
Sep 2013
-
$16.64M(+14.2%)
Jun 2013
-
$14.57M(-17.9%)
Mar 2013
-
$17.74M(-25.5%)
Dec 2012
$80.44M(-9.0%)
$23.82M(+36.6%)
Sep 2012
-
$17.43M(-17.4%)
Jun 2012
-
$21.10M(-10.4%)
Mar 2012
-
$23.54M(-27.0%)
Dec 2011
$88.35M(+129.3%)
$32.23M(+20.2%)
Sep 2011
-
$26.82M(-4.7%)
Jun 2011
-
$28.14M(-10.1%)
Mar 2011
-
$31.30M(-15.5%)
Dec 2010
$38.54M(-47.7%)
$37.02M(+4.9%)
Sep 2010
-
$35.29M(-18.7%)
Jun 2010
-
$43.40M(-13.9%)
Mar 2010
-
$50.39M(-26.1%)
Dec 2009
$73.64M
$68.17M(+13.8%)
DateAnnualQuarterly
Sep 2009
-
$59.90M(-13.8%)
Jun 2009
-
$69.47M(+2.6%)
Mar 2009
-
$67.69M(-27.9%)
Dec 2008
$77.52M(+22.4%)
$93.93M(+9.3%)
Sep 2008
-
$85.97M(-10.6%)
Jun 2008
-
$96.11M(-5.7%)
Mar 2008
-
$101.90M(-7.3%)
Dec 2007
$63.34M(-30.0%)
$109.94M(-5.0%)
Sep 2007
-
$115.78M(-12.4%)
Jun 2007
-
$132.18M(-69.1%)
Mar 2007
-
$427.95M(+81.7%)
Dec 2006
$90.50M(-50.2%)
$235.56M(+265.1%)
Sep 2006
-
$64.53M(-43.3%)
Jun 2006
-
$113.90M(+1.4%)
Mar 2006
-
$112.34M(-15.5%)
Dec 2005
$181.65M(+10.6%)
$132.97M(+13.0%)
Sep 2005
-
$117.71M(+8.4%)
Jun 2005
-
$108.54M(-17.6%)
Mar 2005
-
$131.70M(-21.7%)
Dec 2004
$164.26M(-4.1%)
$168.21M(+34.2%)
Sep 2004
-
$125.33M(+5.5%)
Jun 2004
-
$118.81M(-4.9%)
Mar 2004
-
$124.90M(-12.5%)
Dec 2003
$171.27M(-8.3%)
$142.78M(+34.9%)
Sep 2003
-
$105.86M(+85.8%)
Jun 2003
-
$56.97M(-9.6%)
Mar 2003
-
$63.01M(-28.9%)
Dec 2002
$186.86M(+192.4%)
$88.57M(+83.5%)
Sep 2002
-
$48.27M(-21.2%)
Jun 2002
-
$61.22M(+19.7%)
Mar 2002
-
$51.15M(-4.5%)
Dec 2001
$63.90M(-7.1%)
$53.57M(+3.0%)
Sep 2001
-
$52.03M(-9.6%)
Jun 2001
-
$57.58M(-0.1%)
Mar 2001
-
$57.61M(+29.0%)
Dec 2000
$68.77M(-11.7%)
$44.65M(+1.4%)
Sep 2000
-
$44.04M(-20.7%)
Jun 2000
-
$55.51M(-5.0%)
Mar 2000
-
$58.41M(+3.0%)
Dec 1999
$77.90M(-0.1%)
$56.70M(+3.7%)
Sep 1999
-
$54.70M(+23.8%)
Jun 1999
-
$44.20M(-24.2%)
Mar 1999
-
$58.30M(-25.3%)
Dec 1998
$78.00M(+234.8%)
$78.00M(+69.6%)
Sep 1998
-
$46.00M(-12.0%)
Jun 1998
-
$52.30M(-18.0%)
Mar 1998
-
$63.80M(-24.1%)
Dec 1997
$23.30M(+39.5%)
$84.10M(+53.5%)
Sep 1997
-
$54.80M(-14.9%)
Jun 1997
-
$64.40M(-15.2%)
Mar 1997
-
$75.90M(-11.1%)
Dec 1996
$16.70M(-18.9%)
$85.40M(+67.8%)
Sep 1996
-
$50.90M(-14.5%)
Jun 1996
-
$59.50M(-12.2%)
Mar 1996
-
$67.80M(-7.1%)
Dec 1995
$20.60M(+303.9%)
$73.00M(-1.4%)
Sep 1995
-
$74.00M(+85.5%)
Mar 1995
-
$39.90M(-4.1%)
Dec 1994
$5.10M
$41.60M(-11.1%)
Sep 1994
-
$46.80M(+49.5%)
Jun 1994
-
$31.30M(-18.9%)
Mar 1994
-
$38.60M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual total current assets?
  • What is the all time high annual current assets for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual current assets year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly total current assets?
  • What is the all time high quarterly current assets for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly current assets year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual total current assets?

The current annual current assets of LGND is $331.56M

What is the all time high annual current assets for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual total current assets is $1.12B

What is Ligand Pharmaceuticals Incorporated annual current assets year-on-year change?

Over the past year, LGND annual total current assets has changed by +$94.13M (+39.65%)

What is Ligand Pharmaceuticals Incorporated quarterly total current assets?

The current quarterly current assets of LGND is $309.32M

What is the all time high quarterly current assets for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly total current assets is $1.75B

What is Ligand Pharmaceuticals Incorporated quarterly current assets year-on-year change?

Over the past year, LGND quarterly total current assets has changed by -$59.60M (-16.15%)
On this page